Simon Peter Gampenrieder
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Richard GreilGabriel RinnerthalerTheresa WestphalHubert HacklBrigitte MlineritschLukas WeißFlorian HuemerCornelia Hauser‐Kronberger
- Topics
- HER2/EGFR in Cancer Research (23 papers)Cancer Treatment and Pharmacology (22 papers)Advanced Breast Cancer Therapies (20 papers)
- Partner nations
- AustriaSlovakiaSwitzerland
In The Last Decade
Simon Peter Gampenrieder
52 papers receiving 916 citations
Peers
Comparison fields: 5 of 72
- Oncology 654
- Cancer Research 318
- Molecular Biology 247
- Pulmonary and Respiratory Medicine 245
- Radiology, Nuclear Medicine and Imaging 234
Countries citing papers authored by Simon Peter Gampenrieder
This map shows the geographic impact of Simon Peter Gampenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Peter Gampenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Peter Gampenrieder more than expected).
Fields of papers citing papers by Simon Peter Gampenrieder
This network shows the impact of papers produced by Simon Peter Gampenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Peter Gampenrieder. The network helps show where Simon Peter Gampenrieder may publish in the future.
Co-authorship network of co-authors of Simon Peter Gampenrieder
This figure shows the co-authorship network connecting the top 25 collaborators of Simon Peter Gampenrieder. A scholar is included among the top collaborators of Simon Peter Gampenrieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Peter Gampenrieder. Simon Peter Gampenrieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 151 | |
| 8 | 3 | |
| 9 | 26 | |
| 10 | 13 | |
| 11 | 4 | |
| 12 | 12 | |
| 13 | 6 | |
| 14 | 6 | |
| 15 | 1 | |
| 16 | Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis. | 31 |
| 17 | 57 | |
| 18 | 10 | |
| 19 | 22 | |
| 20 | 28 |
About Simon Peter Gampenrieder
Simon Peter Gampenrieder is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 937 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (23 papers), Cancer Treatment and Pharmacology (22 papers) and Advanced Breast Cancer Therapies (20 papers). The work is most often cited by research in Oncology (654 citations), Cancer Research (318 citations) and Radiology, Nuclear Medicine and Imaging (234 citations). Simon Peter Gampenrieder has collaborated with scholars based in Austria, Slovakia and Switzerland. Frequent co-authors include Richard Greil, Gabriel Rinnerthaler, Theresa Westphal, Hubert Hackl, Brigitte Mlineritsch, Lukas Weiß, Florian Huemer, Cornelia Hauser‐Kronberger, Rupert Bartsch and Georg Hutarew. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.